Technical Analysis for NBTX - Nanobiotix S.A.

Grade Last Price % Change Price Change
D 15.66 -3.21% -0.52
NBTX closed down 0.12 percent on Monday, April 12, 2021, on 8 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical NBTX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.21%
Narrow Range Bar Range Contraction -3.21%
NR7 Range Contraction -3.21%
Weak + Overbought Other -3.21%
Inside Day Range Contraction -3.21%
Weak, Overbought and Reversal Signs Reversal -3.21%
Overbought Stochastic Strength -3.21%
Fell Below 50 DMA Bearish -3.33%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.33%
Volume Surge Other -3.33%
Older End-of-Day Signals for NBTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 3 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Fell Below 20 DMA about 3 hours ago
Fell Below 10 DMA about 3 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

Is NBTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.55
52 Week Low 12.85
Average Volume 8,122
200-Day Moving Average 0.00
50-Day Moving Average 16.63
20-Day Moving Average 15.82
10-Day Moving Average 15.75
Average True Range 0.79
ADX 29.76
+DI 13.96
-DI 26.99
Chandelier Exit (Long, 3 ATRs ) 14.51
Chandelier Exit (Short, 3 ATRs ) 15.22
Upper Bollinger Band 16.86
Lower Bollinger Band 14.78
Percent B (%b) 0.67
BandWidth 13.14
MACD Line -0.13
MACD Signal Line -0.28
MACD Histogram 0.1559
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.34
Resistance 3 (R3) 16.36 16.32 16.31
Resistance 2 (R2) 16.32 16.28 16.31 16.30
Resistance 1 (R1) 16.25 16.26 16.23 16.23 16.29
Pivot Point 16.22 16.22 16.21 16.21 16.22
Support 1 (S1) 16.15 16.17 16.13 16.13 16.07
Support 2 (S2) 16.11 16.15 16.10 16.06
Support 3 (S3) 16.04 16.11 16.05
Support 4 (S4) 16.02